Strides receives USFDA approval for anti-inflammatory Celecoxib Capsules
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
The consideration for the medicines in India is valued at Rs 180.48 crore
Subscribe To Our Newsletter & Stay Updated